Cumberland Pharmaceuticals Inc
CPIX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001087294
No open-market purchases or sales by Cumberland Pharmaceuticals Inc insiders were filed in the last 90 days; 32 institutions reported holding it in 13F filings for Q2 2026, worth $16.0M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Cumberland Pharmaceuticals Inc as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 26
- +3 vs. Q3 2021
- Shares held
- 2.84M
- +67.3K (+2.4%) vs. Q3 2021
- Total value
- $13.2M
- +$5.80M (+78.1%) vs. Q3 2021
- New holders
- 7
- 5 more added
- Sold out
- 4
- 7 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CPIX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 32 | $16.0M |
| Q1 2026 | 29 | $8.97M |
| Q4 2025 | 27 | $11.8M |
| Q3 2025 | 30 | $10.6M |
| Q2 2025 | 31 | $12.3M |
| Q1 2025 | 33 | $18.1M |
| Q4 2024 | 20 | $4.36M |
| Q3 2024 | 22 | $2.61M |
| Q2 2024 | 23 | $3.18M |
| Q1 2024 | 23 | $3.63M |
| Q4 2023 | 25 | $3.89M |
| Q3 2023 | 21 | $4.17M |
| Q2 2023 | 23 | $3.52M |
| Q1 2023 | 21 | $4.77M |
| Q4 2022 | 23 | $5.61M |
| Q3 2022 | 17 | $5.89M |
| Q2 2022 | 22 | $5.62M |
| Q1 2022 | 26 | $8.17M |
| Q4 2021 | 26 | $13.2M |
| Q3 2021 | 23 | $7.43M |
| Q2 2021 | 28 | $8.36M |
| Q1 2021 | 31 | $9.77M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Cumberland Pharmaceuticals Inc; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Dimensional Fund Advisors LP | 652,561 | $3.05M | 0.00% | −44,093−6.3% | Reduced |
| Renaissance Technologies LLC | 606,663 | $2.83M | 0.00% | −57,901−8.7% | Reduced |
| Vanguard Group Inc | 391,179 | $1.83M | 0.00% | −417−0.1% | Reduced |
| Bridgeway Capital Management, LLC | 236,255 | $1.10M | 0.02% | +75,268+46.8% | Added |
| Berkshire Asset Management LLC | 182,141 | $851.0K | 0.05% | +5,956+3.4% | Added |
| Acadian Asset Management LLC | 147,294 | $683.0K | 0.00% | −14,923−9.2% | Reduced |
| BlackRock Inc. | 137,733 | $643.0K | 0.00% | −195,318−58.6% | Reduced |
| Two Sigma Investments, LP | 82,920 | $387.0K | 0.00% | +82,920 | New |
| Marshall Wace, LLP | 79,836 | $373.0K | 0.00% | +79,836 | New |
| State Street Corp | 65,790 | $307.0K | 0.00% | +65,790 | New |
| Geode Capital Management, LLC | 51,493 | $240.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 36,500 | $170.0K | 0.00% | +36,500 | New |
| Two Sigma Securities, LLC | 22,354 | $104.0K | 0.02% | +22,354 | New |
| Sterling Financial Planning, Inc. | 22,031 | $103.0K | 0.06% | 00.0% | Unchanged |
| Arrowstreet Capital, Limited Partnership | 21,238 | $99.0K | 0.00% | +21,238 | New |
| Northern Trust Corp | 20,617 | $96.0K | 0.00% | +396+2.0% | Added |
| Schonfeld Strategic Advisors LLC | 20,200 | $94.0K | 0.00% | +20,200 | New |
| Bank of New York Mellon Corp | 19,843 | $93.0K | 0.00% | 00.0% | Unchanged |
| United Capital Financial Advisers, LLC | 16,246 | $76.0K | 0.00% | 00.0% | Unchanged |
| Parametric Portfolio Associates LLC | 10,466 | $49.0K | 0.00% | −2,410−18.7% | Reduced |
| Tower Research Capital LLC (TRC) | 6,179 | $29.0K | 0.00% | +1,565+33.9% | Added |
| Oakworth Capital, Inc. | 3,052 | $14.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 2,671 | $12.0K | 0.00% | −501−15.8% | Reduced |
| Huntington National Bank | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 124 | $0 | 0.00% | +20+19.2% | Added |
| Wells Fargo & Company | 52 | $0 | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −12,021−100.0% | Sold out |
| Cambridge Investment Research Advisors, Inc. | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −5,198−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −1,933−100.0% | Sold out |